These days are very exciting, but the question is will we reach the endpoint next year? The number of samples in the phase 2 is too small, and the eGFR was added in the phase3. Considering the failure of dkd, any thoughts？
These days are very exciting, but the question is will we reach...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.005(1.49%) |
Mkt cap ! $184.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $637.2K | 1.917M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 268166 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 111071 | 15 |
View Market Depth
| Last trade - 12.41pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
-0.005 ( 1.49 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 34.0¢ | 33.0¢ | 1219928 | ||
| Last updated 12.50pm 10/05/2024 ? | |||||
| DXB (ASX) Chart |